Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?

Diabetes
G M Dallinga-ThieEric J G Sijbrands

Abstract

Plasma phospholipid transfer protein (PLTP) plays an important role in lipoprotein metabolism. PLTP activity is elevated in patients with diabetes, a condition with strongly elevated risk for coronary heart disease. The aim of this study was to test the hypothesis that statins reduce PLTP activity and to examine the potential role of apolipoprotein E (apoE). PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily). At baseline, PLTP activity was positively correlated with waist circumference, HbA(1c), glucose, and apoE (all P < 0.05). Atorvastatin treatment resulted in decreased PLTP activity (10 mg atorvastatin: -8.3%, P < 0.05; 80 mg atorvastatin: -12.1%, P < 0.002). Plasma apoE decreased by 28 and 36%, respectively (P < 0.001). The decrease in apoE was strongly related to the decrease in PLTP activity (r = 0.565, P < 0.001). The change in apoE remained the sole determinant of the change in PLTP activity in a multivariate model. The activity of PLTP in type 2 diabetes is decreased by atorvastatin. The association between the decrease in PLTP activity and...Continue Reading

References

Apr 15, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·R van HaperenR de Crom
Feb 21, 2002·The Journal of Biological Chemistry·Minna KärkkäinenChristian Ehnholm
Mar 14, 2002·Current Opinion in Lipidology·Arie van Tol
Oct 10, 2002·The Journal of Biological Chemistry·Rien van HaperenRini de Crom
Oct 29, 2002·Journal of Lipid Research·Jessica LieArie van Tol
Jun 18, 2003·Journal of Lipid Research·Sarah SigginsChristian Ehnholm
Jul 12, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Xiao Ping YangXian-Cheng Jiang
Aug 13, 2003·Current Atherosclerosis Reports·Gerald M Reaven
Aug 30, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Axel SchlittXian-Cheng Jiang
Nov 18, 2003·Journal of Lipid Research·Sarah SigginsChristian Ehnholm
May 4, 2004·Atherosclerosis. Supplements·Philip Barter
May 29, 2004·Current Opinion in Lipidology·John J Albers, Marian C Cheung
Dec 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Catherine DesrumauxLaurent Lagrost
Feb 8, 2005·Atherosclerosis·O Stein, Y Stein
Apr 23, 2005·Biochemical and Biophysical Research Communications·Minna T JänisChristian Ehnholm

❮ Previous
Next ❯

Citations

Mar 31, 2009·European Journal of Internal Medicine·T MeasP J Guillausseau
Aug 14, 2008·Metabolic Syndrome and Related Disorders·Abdul Basit, A Samad Shera
Nov 11, 2006·Current Opinion in Lipidology·David Akopian, Jheem D Medh
Nov 1, 2006·International Journal of Clinical Practice·A Barnett
Mar 24, 2009·Biochimica Et Biophysica Acta·G M Dallinga-ThieUNKNOWN Diabetes Atorvastatin lipid intervention (DALI) study group
May 6, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·T TzotzasL Lagrost
Oct 14, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Ruijie LiuXian-Cheng Jiang
Jan 23, 2021·The Cochrane Database of Systematic Reviews·Muhammad Ismail ShawishJames M Wright

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.